326 related articles for article (PubMed ID: 21887456)
1. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
Yamaguchi M; Arbiser JL; Weitzmann MN
Int J Mol Med; 2011 Dec; 28(6):1049-53. PubMed ID: 21887456
[TBL] [Abstract][Full Text] [Related]
2. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
[TBL] [Abstract][Full Text] [Related]
3. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
4. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression.
Chao LK; Liao PC; Ho CL; Wang EI; Chuang CC; Chiu HW; Hung LB; Hua KF
J Agric Food Chem; 2010 Mar; 58(6):3472-8. PubMed ID: 20192217
[TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells.
Zhang P; Liu X; Zhu Y; Chen S; Zhou D; Wang Y
Neurosci Lett; 2013 Feb; 534():123-7. PubMed ID: 23262090
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Oh JH; Kang LL; Ban JO; Kim YH; Kim KH; Han SB; Hong JT
Chem Biol Interact; 2009 Aug; 180(3):506-14. PubMed ID: 19539808
[TBL] [Abstract][Full Text] [Related]
8. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes.
Chen YJ; Tsai KS; Chan DC; Lan KC; Chen CF; Yang RS; Liu SH
J Orthop Res; 2014 Apr; 32(4):573-80. PubMed ID: 24375705
[TBL] [Abstract][Full Text] [Related]
9. Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators.
Choi EM
Int Immunopharmacol; 2011 Oct; 11(10):1541-5. PubMed ID: 21621646
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2011 Jan; 27(1):3-14. PubMed ID: 21072493
[TBL] [Abstract][Full Text] [Related]
11. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
Kumar A; Kumar Singh U; Chaudhary A
Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
[TBL] [Abstract][Full Text] [Related]
12. Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model.
Qiu L; Xu R; Wang S; Li S; Sheng H; Wu J; Qu Y
Exp Mol Med; 2015 Jul; 47(7):e171. PubMed ID: 26138903
[TBL] [Abstract][Full Text] [Related]
13. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
[TBL] [Abstract][Full Text] [Related]
14. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
Vaid M; Sharma SD; Katiyar SK
Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
[TBL] [Abstract][Full Text] [Related]
15. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
Ahn KS; Sethi G; Shishodia S; Sung B; Arbiser JL; Aggarwal BB
Mol Cancer Res; 2006 Sep; 4(9):621-33. PubMed ID: 16966432
[TBL] [Abstract][Full Text] [Related]
16. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
Yamaguchi M; Moore TW; Sun A; Snyder JP; Shoji M
Integr Biol (Camb); 2012 Aug; 4(8):905-13. PubMed ID: 22751853
[TBL] [Abstract][Full Text] [Related]
17. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2011 Oct; 28(4):521-5. PubMed ID: 21769418
[TBL] [Abstract][Full Text] [Related]
18. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
19. RANKL-induced osteoclastogenesis is suppressed by 4-O-methylhonokiol in bone marrow-derived macrophages.
Park KR; Kim JY; Kim EC; Yun HM; Hong JT
Arch Pharm Res; 2017 Aug; 40(8):933-942. PubMed ID: 28736799
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
